Skip to content

Aquagenic Wrinkling Prediction

Using Aquagenic Wrinkling to Predict CF Carrier State

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06831110
Enrollment
2000
Registered
2025-02-17
Start date
2025-03-06
Completion date
2026-12-01
Last updated
2026-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aquagenic Wrinkling of Palms, Carrier State

Brief summary

The goal of this observational study is to determine whether an aquagenic wrinkling procedure (i.e., soaking hands in a water bath for up to 20 minutes) can be used as a screening tool for cystic fibrosis carrier status. Participants will complete one visit where they will undergo an aquagenic wrinkling procedure to see how their hands respond.

Interventions

PROCEDUREAquagenic Wrinkling

Participants will be asked to remove all jewelry from the hand(s) and wrist(s) that will be undergoing the aquagenic wrinkling procedures. Photographs will be taken of the palmar surface of the hand(s). The participant will submerge the hand(s) undergoing testing in a water bath for one minute. After one minute, they will remove their hand(s), dry them gently with a towel, and photographs will be taken of the palmar surface of the hand(s). The participant will re-submerge their hand(s) in the appropriate conditions for another minute and the process will be repeated 20 times for 20 total minutes submerged in the water.

Sponsors

University of Iowa
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

* Interested in participating in other CF Carrier-related research studies.

Exclusion criteria

* CF patient status * Unable to speak English * Unable to provide written informed consent * Prisoner status * An open wound on either hand * A tattoo on either hand * Missing any portion of either hand * Diagnosis of Diabetes * Diagnosis of Hyperhidrosis * Diagnosis of Raynaud's Disease * Diagnosis of Atopic Dermatitis * Regularly taking ACE inhibitors or angiotensin receptor blockers

Design outcomes

Primary

MeasureTime frameDescription
Human Observation of WrinklingUp to 20 minutesPhotos of hands will be scored on a scale of 0 (no wrinkling) to 4 (severe wrinkling) at each minute by human observers.
Machine-Learning Observation of WrinklingUp to 20 minutesPhotos of hands will be scored by a machine-learning algorithm at each minute.

Countries

United States

Contacts

CONTACTPhilip M Polgreen, MD
philip-polgreen@uiowa.edu319-384-6194
CONTACTShelby L Francis, PhD
shelby-francis@uiowa.edu319-678-8037
PRINCIPAL_INVESTIGATORPhilip M Polgreen, MD

University of Iowa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 5, 2026